Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Coronary Artery Disease
Interventions
DEVICE

MyoVista device

MyoVista device is a standard EKG device with additional capabilities in detecting cellular level myocardial electrophysiological signals. The device involves placing leads on the chest, similar to a traditional EKG device

DEVICE

Computed tomographic coronary angiography

Traditional method of detecting coronary artery disease. CTA will be performed using 64-detector row or higher scanners with electrocardiographic gating in accordance with the Society of Cardiovascular Computed Tomography (SCCT) guidelines. Approximately 80 to 100 ml of intravenous contrast, followed by 50 to 80 ml of saline, will be administered at a rate of 5 ml/s via a power injector through an antecubital vein (on forearm near the elbow).

DEVICE

Transthoracic Echocardiography

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors
All Listed Sponsors
collaborator

Heart Test Laboratories, Inc.

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER